USA Compounding Pharmacies Market By 2023 to 2033: Future Opportunities and Challenges

 The USA compounding pharmacies market is on an impressive growth trajectory, poised to reach a valuation of USD 11,099.0 million by 2023, according to the latest market analysis. This robust expansion is driven by the increasing demand for personalized medication solutions tailored to individual patient needs.

From 2023 to 2033, the sector is expected to sustain a strong compound annual growth rate (CAGR) of 7.8%, culminating in an estimated market value of approximately USD 23,430.35 million by the end of the forecast period. This growth is primarily attributed to the critical need to enhance medication safety and efficacy through customized pharmaceutical solutions.

Get your PDF Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-us-978

Compounding pharmacies play a crucial role in the healthcare landscape by providing personalized pharmaceuticals that are not readily available in the mass market. These pharmacies address specific patient requirements, from customized dosages to alternative ingredients, thereby filling a significant gap in healthcare delivery.

Key Drivers of Market Growth:

  • Rising Prevalence of Chronic Diseases: The increasing incidence of chronic conditions is fueling the demand for tailored treatment solutions.
  • Need for Specialized Treatments: There is a growing need for customized medications for rare diseases and conditions.
  • Medication Alternatives: The rising prevalence of allergies and intolerances drives demand for alternative medication solutions.

Market Highlights:

  • The USA compounding pharmacies market grew at a CAGR of 5.2% from 2018 to 2022.
  • The oral and topical medicine sectors are anticipated to dominate, with the sector's regional market share exceeding 60% in 2022.
  • Hormone Replacement Therapy (HRT) saw an increase in market share, reaching 39% in 2022.
  • Regular pharmacies accounted for over 27% of the market share in 2022.

Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI), commented, “The market will see substantial growth during the projected period due to the rising prevalence of chronic illnesses like cancer and increased financing for compounding pharmacies in the USA.”

Competitive Landscape: Prominent players in the USA compounding pharmacies market include:

  • Avella Specialty Pharmacy
  • Central Admixture Pharmacy Services Inc.
  • Hoye’s Pharmacy
  • Vertisis Custom Pharmacy
  • Smith Caldwell Drug Store
  • Sixth Avenue Medical Pharmacy
  • Cantrell Drug Company
  • Clinigen Group
  • Dougherty’s Pharmacy
  • Fagron N.V.

Recent Developments:

  • Adamis Pharmaceuticals Corporation announced in 2021 the sale of US Compounding Inc.'s assets for USD 15 million.
  • Harrow revealed in 2023 that its subsidiary ImprimisRx will offer patent-pending compounded Atropine formulations.
  • Nephron Pharmaceuticals Corporation launched a new syringe presentation in 2022 as part of its successful Nephron 503B Outsourcing Facility business.

Market Segmentation:

  • By Product: Oral Medication (Solid, Liquid), Topical Medication, Injectable, Mouthwashes, Nasal, Ocular, Otic, Suppositories and Enemas.
  • By Pharmacy Type: 503A Pharmacy, 503B Pharmacy.
  • By Application: Adults, Pediatrics, Geriatrics, Veterinary.
  • By Therapeutic Area: Hormone Replacement Therapy, Pain Management, Dermatology, Oncology, Hematology, Dental, Others.

Comments

Post a Comment

Popular posts from this blog

Technological Advancements Fueling the Physiotherapy Equipment Market By 2023 to 2033

 The physical well-being and quality of life of people who are recuperating from injuries or who have chronic diseases are greatly enhanced by physical therapy. The Physiotherapy Equipment Market has experienced growth in tandem with the increase in demand for physiotherapy services. Due in large part to technological innovation, the prevalence of neurological and musculoskeletal illnesses is rising, and this sector of the economy is expanding quickly. The market for physiotherapy equipment has a large selection of gadgets and instruments made to help with the healing process. The industry has made considerable strides to meet a variety of treatment demands, from heat and cold therapy devices to electrotherapy machines and therapeutic exercise equipment. These contemporary resources help physiotherapists deliver more focused care, increase patient results, and enrich the therapeutic process as a whole. Grab Your Exclusive Report: Unveiling the Spectacular Growth of the Physiotherapy E
Read more

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/samp
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital stay for the patient, enc
Read more